Dialysis provider DaVita, El Segundo, Calif., said it expects the Federal Trade Commission to require DaVita to divest 60 dialysis centers, or 5% of the facilities involved, to clear the company's $3 billion acquisition of Gambro U.S. Healthcare, a division of Swedish company Gambro.
DaVita said it had not yet reached an agreement with the FTC. After the deal, DaVita expects to operate 1,200 dialysis centers, treat 96,000 patients and generate $4.4 billion in revenue. The company reported net income of $56.3 million, or 55 cents per share, on revenue of $609 million for the quarter ended March 31. That was up about 6% from net income of $52.9 million, or 51 cents per share, on revenue of $535 million, in the year-ago quarter.